Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
917 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01227928 | Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women | completed | Phase 2 | 145 | GlaxoSmithKlineINDUSTRY | 4 | Mar 3, 2015 | clinicaltrials |
| NCT01389583 | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT01608841 | The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib | unknown | Phase 2 | 88 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT01998919 | A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | completed | Phase 2 | 154 | Hoffmann-La RocheINDUSTRY | 8 | Jan 13, 2015 | clinicaltrials |
| NCT01290718 | A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. | terminated | Phase 2 | 4 | Hoffmann-La RocheINDUSTRY | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00531960 | A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. | completed | Phase 2 | 124 | Hoffmann-La RocheINDUSTRY | 13 | Nov 11, 2014 | clinicaltrials |
| NCT00700180 | A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 2 | 303 | Hoffmann-La RocheINDUSTRY | 16 | Sep 25, 2014 | clinicaltrials |
| NCT00475670 | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer | completed | Phase 2 | 44 | Hoffmann-La RocheINDUSTRY | 15 | Sep 15, 2014 | clinicaltrials |
| NCT01579578 | Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer | terminated | Phase 2 | 39 | AstraZenecaINDUSTRY | 5 | Sep 12, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT01678313 | Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | completed | Phase 2 | 140 | Buddhist Tzu Chi General HospitalOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT00605722 | A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. | completed | Phase 2 | 51 | Hoffmann-La RocheINDUSTRY | 3 | Jul 14, 2014 | clinicaltrials |
| NCT02013830 | A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 4 | Jun 6, 2014 | clinicaltrials |
| NCT01142479 | Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy | completed | Phase 2 / Phase 3 | 60 | Taipei City HospitalOTHER_GOV | 1 | May 29, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT02133677 | A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases | unknown | Phase 2 | 24 | Far Eastern Memorial HospitalOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT02132988 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer | unknown | Phase 2 | 110 | Mackay Memorial HospitalOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT02085395 | Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis(AK) | completed | Phase 2 | 27 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 1 | Mar 14, 2014 | clinicaltrials |
| NCT02070497 | Effectiveness of Nursing Case Management for Lung Cancer Patients | completed | Phase 2 | 415 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00910741 | NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia | completed | Phase 1 / Phase 2 | 40 | NanoCarrier Co., Ltd.INDUSTRY | 2 | Jan 9, 2014 | clinicaltrials |
| NCT01600742 | Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis | terminated | Phase 2 | 4 | National Taiwan University HospitalOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT01370876 | Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | Nang Kuang Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 10, 2013 | clinicaltrials |
| NCT02004795 | BNCT and IG-IMRT for Recurrent Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 28 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00292695 | A Phase II Study of Nasal NK/T-cell Lymphoma | completed | Phase 2 | 33 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00359333 | Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST(STS) | completed | Phase 2 | 58 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01533233 | Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients | unknown | Phase 1 / Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT01281696 | Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01231581 | Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer | completed | Phase 2 | 160 | GlaxoSmithKlineINDUSTRY | 2 | Sep 26, 2013 | clinicaltrials |
| NCT01204177 | Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) | completed | Phase 2 | 70 | BayerINDUSTRY | 4 | Sep 6, 2013 | clinicaltrials |
| NCT00862082 | Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 1 / Phase 2 | 14 | Proacta, IncorporatedINDUSTRY | 4 | Aug 23, 2013 | clinicaltrials |
| NCT00632268 | Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT01914458 | Image Discovering Early Lung Cancer Project(IDEALCAP) | unknown | Phase 2 | 600 | Cathay General HospitalOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00166881 | Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin(P-HDFL-DI) | completed | Phase 2 | 29 | National Taiwan University HospitalOTHER | 1 | Jul 8, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT00517790 | Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | AbbVie (prior sponsor, Abbott)INDUSTRY | 5 | Apr 5, 2013 | clinicaltrials |
| NCT01463059 | Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy | completed | Phase 2 | 119 | UCB Japan Co. Ltd.INDUSTRY | 3 | Mar 25, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT01658358 | ErbB2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 15 | China Medical University HospitalOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT00517920 | Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 44 | AbbVie (prior sponsor, Abbott)INDUSTRY | 4 | Jan 4, 2013 | clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00275951 | Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer(FLAG) | completed | Phase 2 | 39 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2012 | clinicaltrials |
| NCT01727635 | The Long-term Effects of Body-mind-spirit Group Therapy | completed | Phase 2 / Phase 3 | 60 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2012 | clinicaltrials |
| NCT01359501 | Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients | unknown | Phase 2 | 100 | China Medical University HospitalOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00737360 | Phase II Study of TAS-106 to Treat Head and Neck Cancer | terminated | Phase 2 | 27 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 4 | Sep 5, 2012 | clinicaltrials |
| NCT00338884 | Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer | completed | Phase 2 | 120 | PfizerINDUSTRY | 6 | Aug 31, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials